| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.24▲ | 3.14▲ | 3.15▲ | 3.42▼ | 3.37▼ |
| MA10 | 3.18▲ | 3.13▲ | 3.21▲ | 3.42▼ | 3.24▲ |
| MA20 | 3.14▲ | 3.21▲ | 3.37▼ | 3.45▼ | 3.71▼ |
| MA50 | 3.12▲ | 3.40▼ | 3.46▼ | 3.28▲ | 3.80▼ |
| MA100 | 3.20▲ | 3.45▼ | 3.38▼ | 3.81▼ | 3.60▼ |
| MA200 | 3.35▼ | 3.40▼ | 3.39▼ | 3.90▼ | 4.66▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.022▲ | 0.013▲ | -0.017▼ | -0.011▼ | -0.040▼ |
| RSI | 78.770▲ | 52.371▲ | 46.182▼ | 46.019▼ | 45.812▼ |
| STOCH | 88.545▲ | 36.704 | 19.593▼ | 58.079 | 41.583 |
| WILL %R | -7.317▲ | -32.857 | -54.808 | -65.957 | -65.084 |
| CCI | 155.556▲ | 73.070 | -11.187 | -101.710▼ | -21.545 |
|
Tuesday, May 12, 2026 01:23 PM
SG293 represents a differentiated in vivo CAR T cell approach designed to work without lymphodepletion to deliver potent therapeutic activity and exceptional specificity to minimize off-target effects ...
|
|
Monday, May 11, 2026 02:11 PM
Sana reported positive 14-month data from an investigator-sponsored trial of UP421, showing ongoing survival and function of transplanted pancreatic beta cells without immunosuppression. The company ...
|
|
Monday, May 11, 2026 01:24 PM
Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/05/26 | 3.21 | 3.30 | 3.05 | 3.285 | 2,871,908 |
| 12/05/26 | 3.52 | 3.585 | 3.245 | 3.26 | 4,515,371 |
| 11/05/26 | 3.57 | 3.75 | 3.51 | 3.56 | 2,243,446 |
| 08/05/26 | 3.45 | 3.565 | 3.45 | 3.51 | 1,604,563 |
| 07/05/26 | 3.62 | 3.6211 | 3.4401 | 3.50 | 2,134,698 |
| 06/05/26 | 3.49 | 3.71 | 3.48 | 3.64 | 3,566,213 |
| 05/05/26 | 3.47 | 3.56 | 3.37 | 3.49 | 1,608,276 |
| 04/05/26 | 3.25 | 3.42 | 3.25 | 3.41 | 1,759,615 |
| 01/05/26 | 3.29 | 3.32 | 3.18 | 3.27 | 1,580,640 |
| 30/04/26 | 3.27 | 3.41 | 3.222 | 3.29 | 2,917,940 |
|
|
||||
|
|
||||
|
|